Study 2018-53-01 (part one) (HTA) Immunoglobulins

Ongoing study - This first part aims at critically assessing, via a rapid review, the available evidence on the effectiveness and cost-effectiveness of Immunoglobulins. It will also describe and compare the reimbursement/funding systems for Immunoglobulins in Belgium and 4 other countries. 

This study will be complemented by a second part.

Published on: